A detailed history of Allianz Asset Management Gmb H transactions in Amgen Inc stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 600 shares of AMGN stock, worth $187,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares
600
Previous 1,276,258 99.95%
Holding current value
$187,470
Previous $368 Million 99.95%
% of portfolio
0.0%
Previous 0.7%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $19.8 Million - $23.9 Million
73,568 Added 5.76%
1,349,826 $384 Million
Q4 2023

Feb 12, 2024

SELL
$255.7 - $288.46 $48.9 Million - $55.1 Million
-191,187 Reduced 13.03%
1,276,258 $368 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $17.6 Million - $21.9 Million
80,684 Added 5.82%
1,467,445 $394 Million
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $18.6 Million - $22 Million
-86,780 Reduced 5.89%
1,386,761 $308 Million
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $14.1 Million - $17.2 Million
62,511 Added 4.43%
1,473,541 $356 Million
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $40.6 Million - $51.6 Million
177,377 Added 14.38%
1,411,030 $371 Million
Q3 2022

Nov 08, 2022

SELL
$224.46 - $253.15 $33.2 Million - $37.5 Million
-147,963 Reduced 10.71%
1,233,653 $278 Million
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $40.9 Million - $45.5 Million
-177,159 Reduced 11.37%
1,381,616 $336 Million
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $21.6 Million - $23.9 Million
98,689 Added 6.76%
1,558,775 $377 Million
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $591,668 - $677,110
2,975 Added 0.2%
1,460,086 $329 Million
Q3 2021

Nov 10, 2021

BUY
$212.27 - $248.7 $156 Million - $183 Million
736,056 Added 102.08%
1,457,111 $310 Million
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $19.8 Million - $22 Million
-84,800 Reduced 10.52%
721,055 $176 Million
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $7.4 Million - $8.62 Million
33,337 Added 4.32%
805,855 $201 Million
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $22.8 Million - $27.1 Million
-105,173 Reduced 11.98%
772,518 $178 Million
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $72.6 Million - $80.7 Million
-309,206 Reduced 26.05%
877,691 $223 Million
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $35.8 Million - $43.9 Million
-180,824 Reduced 13.22%
1,186,897 $280 Million
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $27.3 Million - $36.3 Million
150,060 Added 12.32%
1,367,721 $277 Million
Q4 2019

Feb 13, 2020

SELL
$189.21 - $243.2 $3.34 Million - $4.29 Million
-17,649 Reduced 1.43%
1,217,661 $294 Million
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $30 Million - $36 Million
-172,365 Reduced 12.24%
1,235,310 $239 Million
Q2 2019

Aug 08, 2019

SELL
$166.7 - $195.41 $87.8 Million - $103 Million
-526,821 Reduced 27.23%
1,407,675 $259 Million
Q1 2019

May 13, 2019

BUY
$180.87 - $203.88 $23.6 Million - $26.6 Million
130,523 Added 7.24%
1,934,496 $368 Million
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $20.9 Million - $24.4 Million
117,187 Added 6.95%
1,803,973 $351 Million
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $57.4 Million - $64.7 Million
309,676 Added 22.49%
1,686,786 $350 Million
Q2 2018

Aug 13, 2018

SELL
$166.05 - $186.51 $54.4 Million - $61.1 Million
-327,514 Reduced 19.21%
1,377,110 $254 Million
Q1 2018

May 14, 2018

SELL
$169.43 - $198.0 $163 Million - $191 Million
-964,471 Reduced 36.13%
1,704,624 $291 Million
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $16.4 Million - $18.4 Million
97,451 Added 3.79%
2,669,095 $464 Million
Q3 2017

Nov 13, 2017

SELL
$167.29 - $191.0 $25.1 Million - $28.6 Million
-149,900 Reduced 5.51%
2,571,644 $479 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-165,758 Reduced 5.74%
2,721,544 $469 Million
Q1 2017

Apr 17, 2019

SELL
N/A
-120,969 Reduced 4.02%
2,887,302 $474 Million
Q4 2016

Apr 17, 2019

BUY
N/A
55,206 Added 1.87%
3,008,271 $440 Million
Q3 2016

Apr 17, 2019

BUY
N/A
2,953,065
2,953,065 $491 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.